Mucocis (Carbocisteine)

Carbocisteine reduces mucus viscosity by breaking disulfide bonds in mucopolysaccharide chains. This makes secretions less thick, allowing ciliary motion and coughing to more efficiently clear airway secretions.

The prescribed dose of carbocisteine is determined by the treating physician based on the patient’s age, severity of symptoms and renal function. Dosage forms and regimens vary, and the prescriber sets the appropriate schedule.

Safety data for carbocisteine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified health professional.

To place an order, submit an enquiry on the Mucocis product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Carbocisteine differs from agents such as acetylcysteine by primarily breaking disulfide bonds in mucus rather than acting as a direct antioxidant. It is generally well‑tolerated and may be preferred when a gentler mucolytic effect is desired, though clinical choice depends on patient factors and physician judgment.

Mucocis should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain stability.

Mucocis is taken orally, usually with a glass of water. The tablet or liquid should be swallowed whole and not chewed, unless the specific dosage form advises otherwise. Administration timing (e.g., with meals) is guided by the prescribing clinician.

Although uncommon, serious adverse reactions can include severe allergic responses such as anaphylaxis, skin reactions like Stevens‑Johnson syndrome, hepatic dysfunction, neutropenia and bronchospasm. Patients should seek immediate medical attention if they experience any of these symptoms.

Individuals with known hypersensitivity to carbocisteine or any excipients in the product should avoid Mucocis. Caution is also advised for patients with severe renal or hepatic impairment, and it should not be used in pregnant or breastfeeding women unless clearly indicated by a physician.